SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-012871
Filing Date
2020-02-10
Accepted
2020-02-10 08:42:35
Documents
3
Period of Report
2020-02-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207231-1_8k.htm 8-K 16819
2 EXHIBIT 99.1 tm207231d1_ex99-1.htm EX-99.1 19901
3 GRAPHIC tm20723d1_ex99-1img001.jpg GRAPHIC 17627
  Complete submission text file 0001104659-20-012871.txt   62335
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 20589721
SIC: 2834 Pharmaceutical Preparations